@JohnTStats

Assistant Professor @LSHTM. Biostatistics PhD.

 London, England
lshtm.ac.uk/aboutus/people/tazare.john
Joined January 2017
  • Tweets128
  • Following609
  • Followers353
14Media
UPD countdown to Christmas day 7/15: New guest blog! 🎄 In today’s UPD guest blog, @JohnTStats and Helen Strongman from @ehr_lshtm share their research and discuss their perspectives on the impact of opt-outs on health research. Read below!👇 understandingpatientdata.org…

NHS Data Opt-outs: the missing pieces of the puzzle

Understanding Patient Data supports conversations with the public, patients and healthcare professionals about the uses of health information for care and research.

understandingpatientdata.org.uk
1
186
🚨Our paper on National data opt-outs in 2021 is out in @BJGPOpen !
BJGP Open Journal@BJGPOpen11 Jul 2024
The English NHS data opt-out allows people to prevent use of their health data other than for direct care. Tazare+al describe how opt-outs varied in 2021 by key demographic characteristics, and discuss statistical and epidemiological implications ➡️doi.org/10.3399/BJGPO.2024.0…
1
3
480
John Tazare retweeted
BMJ_Open@BMJ_Open6 Jul 2024
Changes in sick notes associated with COVID-19 from 2020 to 2022: a cohort study in 24 million primary care patients in OpenSAFELY-TPP bit.ly/4d4Sygb @anschaf @johntstats
2
1
528
John Tazare retweeted
CAUSALab@CAUSALab30 Apr 2024
The 17th Kolokotrones Symposium, "UK Secure Data Environments: A New Approach to Population-Scale Real World Evidence,” was a success! Thanks to our speakers for providing valuable insight into the British data model. Presentations now live on YouTube: youtu.be/OkK57xqPOoI?si=786C…
Symposium speakers in front of Harvard T.H. Chan School of Public Health

ALT Symposium speakers in front of Harvard T.H. Chan School of Public Health

Jonathan Sterne moderates the symposium

ALT Jonathan Sterne moderates the symposium

1
5
29
2,219
John Tazare retweeted
CAUSALab@CAUSALab19 Apr 2024
Halfway through our morning sessions at @CAUSALab's #KolokronesSyposium! Now we're learning from @JohnTStats, Statistical Pharmacoepidemiologist at @LSHTM who is presenting on #Causalinference for #therapeutics: OpenSAFELY and #COVID19.
2
1
12
1,295
Looking forward to this @HarvardChanSPH event on Secure Data Environments for medical data & electronic health records, which features a talk from LSHTM's @JohnTStats hsph.harvard.edu/event/uk-se…
3
2
306
Very exciting to see code sharing forming part of the BMJ's new data sharing policy (and not just for trials!). Will be interesting to see how this is implemented and followed 👀
Kamran Abbasi@KamranAbbasi5 Mar 2024
A major new announcement: Mandatory data and code sharing for research published by The BMJ @bmj_latest bmj.com/content/384/bmj.q324

Mandatory data and code sharing for research published by The BMJ

New policy requires authors to share analytic codes from all studies and data from all trials The case for sharing data from clinical research is strong.12 Clinical study data include all information...

bmj.com
2
6
965
Our Letter to the Editor in response to the inclusion of code sharing in @BMJ's newly announced data sharing policy has been published. (bmj.com/content/383/bmj.p240…) #transparency #openscience #reproducibility

The role of programming code sharing in improving the transparency of medical research

Abbasi says that the importance of sharing data and code from research is obvious.1 As epidemiologists, our research involves using large routine healthcare databases, for which data sharing is not a...

bmj.com
1
5
1
36
4,850
@AnnaTheresia and I highlight that, as epidemiologists, much of our research involves the use of data for which sharing is not a legal possibility. Therefore, programming code sharing has an important role in improving the transparency of this research.
1
1
532
The BMJ's policy, alongside other open research indicators, could be monitored with a new "open research" tag at the end of manuscripts which might encourage the reporting of other important transparency indicators in a standardised way - e.g., pre-registration and pre-printing.
1
195
🔊 Our Early Career Researcher Showcase! Join us for an exciting hybrid event on Nov 7th, featuring LSHTM's emerging talents in data and statistical science. Nominate yourself or a colleague by completing the form before the Oct 13th deadline. 👇 bit.ly/3LVoet0
6
1
4
2,679
🚨Want to apply the high-dimensional propensity score algorithm? As well as great software available in SAS and R, there's now a dedicated Stata package for implementing these approaches! doi.org/10.1177/1536867X2311…
4
27
2,114
Join us for inaugural lectures from Jonathan Bartlett, Ruth Keogh and Fizz Williamson "Please mind the methodology gap: biostatistics to the rescue" 📅Thurs 14 September 🕔17:15 UK GMT +1 [BST] 📍LSHTM & online 🔗lshtm.ac.uk/newsevents/event…
2
22
5
58
14,109
Delighted to see our commentary published, outlining the potential for trial emulation with observational data from #CysticFibrosis (CF) registries. By @RuthHKeogh and I on behalf of the CF trial emulation network (CF-TEN) doi.org/10.1016/S2213-2600(2…
5
15
1,126
At #ICPE23 and interested in open science? Come to our symposium, “Sharing is Caring?”, about the sharing of programming code in pharmacoepidemiology at 4.15 in MR201! We’ll have review results, examples and live polls ✨@JohnTStats @Shirley_Wang_V @prieto_alhambra
3
12
1,547
New study shows among people with blood sugar levels below threshold for diabetes: Men with raised blood sugar had 30% greater risk of developing cardiovascular diseases (CVDs) Women with raised blood sugar had 30-50% greater risk of developing CVDs📈👥
Christopher Rentsch quote card, "We quantified differences in the risk of heart disease between men and women across the full range of blood sugar levels."

ALT Christopher Rentsch quote card, "We quantified differences in the risk of heart disease between men and women across the full range of blood sugar levels."

1
12
1
20
4,734
We know the #COVID pandemic disrupted healthcare but did it exacerbate ethnic differences in chronic disease monitoring? A quick dive into a recent @OpenSAFELY @COVID19_LHW @ehr_lshtm paper led by @RcostelloEpi @Ladyroho and @sineadlangan_1 thelancet.com/journals/eclin…
1
11
2
24
7,202
Our review of pioneering applications of the Prevalent New User Design is now published - onlinelibrary.wiley.com/doi/…

Prevalent new user designs: A literature review of current implementation practice

Purpose Prevalent new user (PNU) designs extend the active comparator new user design by allowing for the inclusion of initiators of the study drug who were previously on a comparator treatment. We...

onlinelibrary.wiley.com
1
1
2
451
Reviewing initial applications of a novel methodological proposal allowed us to understand current practice whilst identifying gaps in methodological knowledge and potential barriers to wider uptake.
1
139
Great academic/industry collaboration working with colleagues at @ehr_lshtm, @GSK and @analysisgroup
113
Load more